“Bayer has been working to improve women’s health in Australia for more than 60 years, and with the PBS listing of YAZ and YASMIN, we are proud to demonstrate this commitment to advancing women’s health by providing solutions for her different reproductive needs," said Manoj Saxena, CEO of Bayer Australia and New Zealand and country division head for the pharmaceutical division …
A 'milestone moment' with first oral contraceptive listed on the PBS in over 30 years
March 2, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Eisai and Biogen working on next steps after TGA confirms non-approval of Alzheimer’s therapy
March 4, 2025 - -
CSL Seqirus secures Australia-NZ rights to commercialise cholesterol-lowering biologics
March 4, 2025 - - Latest News -
Is personalised gene therapy ready for prime time?
March 4, 2025 - - Latest News -
Astellas welcomes TGA approval of cancer combination as first-line treatment
March 4, 2025 - - Latest News -
Sandoz backs Australian medicinal cannabis company in ten-year agreement
March 3, 2025 - - BioPharma -
Australian startup launches the world's first commercial biological computer
March 3, 2025 - - Australian Biotech -
TGA approves first biological therapy for serious respiratory condition
March 3, 2025 - - Latest News